Risks of Entry and Infection in Laboratory Animals and Genetically Modified Silkworms
First written in FY2016. 2 of 4 entries say "Restated". Latest entry: FY2020.
No other company in this theme has enough history to compare yet.
- FY2020DroppedAnnual reportThe standalone risk disclosure previously covering intrusion into and infection of laboratory animals and genetically modified silkworms could not be found among the risk items in this filing.
- FY2019RestatedAnnual report
「The Group manages these matters under an adequate security framework. However, if intrusion or harm by third parties or others cannot be completely prevented, contamination of animals or silkworms in sterile facilities could have a significant impact on the Group's business activities.」
Restates the risks of intrusion into research facilities, infection of laboratory animals and silkworms, and reputational impact. - FY2017RestatedAnnual report
「If intrusion or harm by third parties or others cannot be completely prevented, contamination of animals or silkworms in sterile facilities could have a significant impact on the Group's business activities.」
Restates the risks of intrusion into research facilities, infection of laboratory animals and silkworms, and reputational impact. - FY2016First statedAnnual report
「If intrusion or harm by third parties or others cannot be completely prevented, contamination of animals or silkworms in sterile facilities could have a significant impact on the Group's business activities.」
Identifies the potential for intrusion into research facilities, contamination of animals and silkworms, and reputational damage.